Federal Register: February 29, 2008 (Volume 73, Number 41)
DOCID: fr29fe08-50 FR Doc E8-3916
DEPARTMENT OF DEFENSE
Army Department
NOTICE: NOTICES
DOCID: fr29fe08-50
ACTION: Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing:
DOCUMENT ACTION: Notice.
SUBJECT CATEGORY:
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of Invention Described in U.S. Provisional Patent Application Concerning Identification of Staphylococcal Enterotoxin-B (SEB) Sequences Involved in Cell Proliferation and Cell Death
DOCUMENT SUMMARY:
In accordance with 37 CFR 404.4, 404.6 and 404.7, announcement is made of the availability for licensing of the invention described in U.S. Provisional Patent Application No. 60/853,906 entitled ``Identification of Staphylococcal EnterotoxinB (SEB) Sequences Involved in Cell Proliferation and Cell Death,'' filed October 24, 2006. Foreign rights are also available (PCT/US2007/022473). The United States Government, as represented by the Secretary of the Army, has rights in this invention.
SUMMARY:
Identification of Staphylococcal Enterotoxin-B Sequences Involved in Cell Proliferation and Cell Death,
SUPPLEMENTAL INFORMATION
The present invention relates to bacterial
peptides, specifically Staphylococcus Enterotoxin B (SEB) peptides that
have therapeutic use. The invention further relates to the use of SEB
peptides in the diagnosis and therapy of diseases associated with cell proliferation.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. E83916 Filed 22808; 8:45 am]
BILLING CODE 371008P
FOR FURTHER INFORMATION CONTACT
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 6197808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 6196664, both at telefax (301) 6195034.